H. Jeffrey Wilkins's most recent trade in Avalo Therapeutics Inc was a trade of 6,371 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Dec. 10, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avalo Therapeutics Inc | H. Jeffrey Wilkins | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 10 Dec 2021 | 6,371 | 33,373 | - | 1.6 | 10,002 | Common Stock |
| Avalo Therapeutics Inc | H. Jeffrey Wilkins | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 10 Jun 2021 | 912 | 27,002 | - | 2.3 | 2,079 | Common Stock |